Coronavirus disease 2019 (COVID-19) is a current global pandemic. The case number has increased since December 31, 2019. It has been reported that COVID-19 patients have been giving pain complaints, one of which is muscular pain. Other types of pain that have also been reported by COVID-19 patients are joint pain, stomach pain, and testicular pain. Neuropathic pain is the rarest case among others. COVID-19 mechanisms in the nerve and musculoskeletal damage are believed to be caused by the expression and distribution of angiotensin-converting enzyme 2 (ACE-2). Patients with pain, especially neuropathic pain, normally do not respond well to various therapies, and experience psychiatric disorders such as depression, which leads to a decrease in the patient’s quality of life. Important considerations for health professionals in terms of pain management during this pandemic include ensuring treatment continuity, painkillers, utilization of telemedicine, biopsychosocial management approach, and modifying therapy needs to reduce the risks of COVID-19 complications.
【저자키워드】 COVID-19, management, neuropathic pain, muscular pain, 【초록키워드】 Treatment, Coronavirus disease 2019, pandemic, therapy, Depression, risk, angiotensin-converting enzyme 2, COVID-19 complications, global pandemic, ACE-2, Health, Pain, Quality of life, distribution, Other, expression, mechanism, Therapies, COVID-19 patient, psychiatric disorder, Musculoskeletal, professional, approach, decrease, testicular pain, neuropathic, joint, caused, include, reported, reduce, respond, 【제목키워드】 pandemic, COVID-19 infection, clinical manifestation, literature review,